Reckitt Benckiser Group plc (RB or 'the group') is engaged in the production and distribution of household cleaning, health, hygiene and nutrition products. The group operates in Europe, North America, Australia, New Zealand and other developing markets, employing over 43 thousand people across the globe. Reckitt Benckiser's global reach has only expanded over the years, operating in more than 60 countries and generating sales in nearly 200 countries. In 2020, the company generated a global net revenue of approximately 14 billion British pounds. RB's revenues are broken down into three main categories - health, hygiene home and nutrition, with the latter added in 2020. Hygiene home was the most lucrative category that year, generating nearly six billion pounds in worldwide revenues.
Reckitt Benckiser's diverse brand portfolio is made up of globally renowned brands that have become household names across the world, including prominent brands such as Dettol, Durex, Strepsils, Air Wick, Finish, Vanish, Veet, Mucinex and others. In 2019, Reckitt Benckiser was the leading cough/sore throat drops and cough syrup vendor in the United States. With sales exceeding 156 million U.S. dollars, the group surpassed competitors such as Pfizer and Procter & Gamble in that category. In the U.S. market, RB's Durex brand also positions itself among the most widely used male contraceptive brands among U.S. households. However, Church & Dwight, the manufacturer of Trojan condoms, remained the leading vendor in that category in the U.S. in 2019.
Reckitt Benckiser's business strategy is aimed at responding to key global shifts and focusing on where they can make the biggest difference: the need for better health and hygiene behavior and the growing scarcity of water. Focus on reducing environmental impacts across the value chain and maximizing positive impacts on health and hygiene behavior through education and innovation is their top priority.